Literature DB >> 16556497

Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.

M L Essink-Bot1, A J Rijnsburger, S van Dooren, H J de Koning, C Seynaeve.   

Abstract

Magnetic resonance imaging (MRI) of the breasts is a promising screening modality for early detection in women at increased breast cancer risk. We investigated the subjective experiences with MRI and the preferences for MRI, mammography or clinical breast examination in 178 high-risk women adhering to a breast cancer surveillance programme. MRI was reported to cause limited discomfort. About 44% preferred MRI as a screening test (mammography: 14%). MRI provided the most reassurance of breast cancer being absent in case of a favourable test result. MRI seems to be acceptable as a screening test for women at increased breast cancer risk and is preferred by them over mammography.

Entities:  

Mesh:

Year:  2006        PMID: 16556497     DOI: 10.1016/j.breast.2006.02.001

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  5 in total

1.  The burden of endoscopic retrograde cholangiopancreatography (ERCP) performed with the patient under conscious sedation.

Authors:  S M Jeurnink; E W Steyerberg; E J Kuipers; P D Siersema
Journal:  Surg Endosc       Date:  2012-08       Impact factor: 4.584

Review 2.  Current and future trends in photoacoustic breast imaging.

Authors:  Srirang Manohar; Maura Dantuma
Journal:  Photoacoustics       Date:  2019-06-30

3.  Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004.

Authors:  Natasha K Stout; Larissa Nekhlyudov
Journal:  J Womens Health (Larchmt)       Date:  2011-03-17       Impact factor: 2.681

4.  Living my family's story: identifying the lived experience in healthy women at risk for hereditary breast cancer.

Authors:  Meghan L Underhill; Robin M Lally; Marc T Kiviniemi; Christine Murekeyisoni; Suzanne S Dickerson
Journal:  Cancer Nurs       Date:  2012 Nov-Dec       Impact factor: 2.592

5.  Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666.

Authors:  Wendie A Berg; Jeffrey D Blume; Amanda M Adams; Roberta A Jong; Richard G Barr; Daniel E Lehrer; Etta D Pisano; W Phil Evans; Mary C Mahoney; Linda Hovanessian Larsen; Glenna J Gabrielli; Ellen B Mendelson
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.